Chromone-3-carboxylic acid has been researched along with iproniazid in 2 studies
| Studies (Chromone-3-carboxylic acid) | Trials (Chromone-3-carboxylic acid) | Recent Studies (post-2010) (Chromone-3-carboxylic acid) | Studies (iproniazid) | Trials (iproniazid) | Recent Studies (post-2010) (iproniazid) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 1,785 | 8 | 82 |
| Protein | Taxonomy | Chromone-3-carboxylic acid (IC50) | iproniazid (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 6.85 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 7.97 | |
| Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 7.5 | |
| Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 5 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 5.7032 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 5.9633 | |
| C-X-C chemokine receptor type 3 | Homo sapiens (human) | 6.56 | |
| Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | 7.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alcaro, S; Borges, F; Gaspar, A; Milhazes, N; Orallo, F; Ortuso, F; Uriarte, E; Yáñez, M | 1 |
| Borges, F; Fonseca, A; Gaspar, A; Milhazes, N; Reis, J; Uriarte, E; Viña, D | 1 |
2 other study(ies) available for Chromone-3-carboxylic acid and iproniazid
| Article | Year |
|---|---|
Chromone-2- and -3-carboxylic acids inhibit differently monoamine oxidases A and B.
Topics: Binding Sites; Chromones; Computer Simulation; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Protein Isoforms | 2010 |
Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.
Topics: Animals; Cell Line; Chromones; Humans; Inhibitory Concentration 50; Models, Molecular; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurodegenerative Diseases; Protein Isoforms; Structure-Activity Relationship | 2011 |